ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)
38.77
+3.26 (9.18%)
At close: Aug 20, 2026
30.98% (1Y)
| Market Cap | 5.87B +35.2% |
| Revenue (ttm) | 458.30M +48.5% |
| Net Income | -3.52M |
| EPS | -0.02 |
| Shares Out | 151.47M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.20 (0.54%) |
| Ex-Dividend Date | Jul 15, 2026 |
| Volume | 20,950,368 |
| Open | 36.06 |
| Previous Close | 35.51 |
| Day's Range | 35.53 - 39.11 |
| 52-Week Range | 26.38 - 65.03 |
| Beta | -0.23 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 26, 2026 |